Baxter International Inc
BAX: XNYS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| %^# | LOCK|&lVq% | LOCK|>x |
Baxter Earnings: Investors Asked to Wait Longer for Profit Turnaround After Weak 2026 Guidance
In the fourth quarter, Baxter turned in 3% operational sales growth and adjusted EPS of $0.44, a 24% decline and below prior guidance of $0.52 to $0.57. The firm also provided 2026 guidance of flat to 1% reported sales growth and $1.85 to $2.05 of adjusted EPS, or a decline of 7% to 16%.
